Clinical Trial Update: Nanocytology Test to Evaluate Skin Cancer in High Risk Patients [NA]

View source ↗

Summary

Completed clinical trial evaluating a Nanocytology Test to evaluate skin cancer in high-risk patients with actinic keratosis or squamous cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Squamous Cell Carcinoma

Snippet

Sponsor: Northwestern University | Conditions: Actinic Keratosis, Squamous Cell Carcinoma | NA | Status: COMPLETED